Idenix Pharmaceuticals (IDIX +11.4%) pops this morning after saying it's entered into a...

|About: Idenix Pharmaceuticals, Inc. (IDIX)|By:, SA News Editor

Idenix Pharmaceuticals (IDIX +11.4%) pops this morning after saying it's entered into a non-exclusive collaboration with Janssen Pharmaceuticals for the clinical development of antiviral Hepatitis C vaccine combination therapies. The plans include an initial drug-drug interaction study to begin in the first quarter of 2013, followed by phase II studies pending approval from regulatory authorities.